FR1790M - Dérivés d'aralcoylaminopyrimidines et leurs procédés de préparation. - Google Patents

Dérivés d'aralcoylaminopyrimidines et leurs procédés de préparation.

Info

Publication number
FR1790M
FR1790M FR865183A FR865183A FR1790M FR 1790 M FR1790 M FR 1790M FR 865183 A FR865183 A FR 865183A FR 865183 A FR865183 A FR 865183A FR 1790 M FR1790 M FR 1790M
Authority
FR
France
Prior art keywords
aralkyllaminopyrimidine
derivatives
processes
preparation
aralkyllaminopyrimidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR865183A
Other languages
English (en)
French (fr)
Inventor
Allan Poe Gray
Donald Elmer Heitmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Irwin Neisler and Co
IRWIN Co
Original Assignee
Irwin Neisler and Co
IRWIN Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irwin Neisler and Co, IRWIN Co filed Critical Irwin Neisler and Co
Application granted granted Critical
Publication of FR1790M publication Critical patent/FR1790M/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR865183A 1960-11-01 1961-06-16 Dérivés d'aralcoylaminopyrimidines et leurs procédés de préparation. Active FR1790M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6643160A 1960-11-01 1960-11-01

Publications (1)

Publication Number Publication Date
FR1790M true FR1790M (fr) 1963-04-29

Family

ID=22069457

Family Applications (1)

Application Number Title Priority Date Filing Date
FR865183A Active FR1790M (fr) 1960-11-01 1961-06-16 Dérivés d'aralcoylaminopyrimidines et leurs procédés de préparation.

Country Status (7)

Country Link
AT (1) AT241465B (sv)
BE (1) BE603387A (sv)
CH (1) CH413845A (sv)
DE (1) DE1249282B (sv)
DK (1) DK104678C (sv)
FR (1) FR1790M (sv)
GB (1) GB910125A (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
DE50212771D1 (de) 2001-10-17 2008-10-23 Boehringer Ingelheim Pharma Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
BE603387A (fr) 1961-09-01
DE1249282B (sv)
GB910125A (en) 1962-11-07
AT241465B (de) 1965-07-26
CH413845A (de) 1966-05-31
DK104678C (da) 1966-06-20

Similar Documents

Publication Publication Date Title
BE634402A (fr) Dérivés de l'hydrophénanthrène et leurs procédés de préparation
FR1790M (fr) Dérivés d'aralcoylaminopyrimidines et leurs procédés de préparation.
OA00882A (fr) Nouveaux dérivés de l'indane-dione-1,3 et procédés de préparation de ceux-ci.
BE595971A (fr) Dioxy-stéroïdes et leurs procédés de préparation.
BE603407A (fr) Dérivés d'acrylamide de dialdéhyde-polysaccharides.
BE610569A (fr) Procédés pour la préparation de benzhydrylidène-cycloalcanes p,p'-substitués
BE599247R (fr) Esters de l'oxytétracycline et leurs procédés de préparation
FR1265879A (fr) Dérivés substitués en -7 de la théophylline et leurs procédés de préparation
BE602572A (fr) Matières catalytiques et leurs procédés de préparation
FR1317205A (fr) Nouveaux dérivés de l'indane et leurs procédés de préparation
FR1306615A (fr) Nitro-furyl-thiadiazols substitués et leurs procédés de préparation
BE605573A (fr) Nouvelles alkylenebisbenzimidazoles et leurs procédés de préparation
BE584515A (fr) Dérivés du yobimbane et leurs procédés de préparation.
FR1274729A (fr) Nouveaux dérivés arsenicaux et leurs procédés de préparation
FR1339413A (fr) Phosphorinanones et leurs procédés de préparation
FR1279590A (fr) Procédé de préparation d'hydroxyprégnanes et de leurs dérivés fonctionnels
BE604996A (fr) Dérivés de la 1,2,3,4-tétrahydroquinazolinone et leur préparation
FR3591M (fr) Nouveaux dérivés de l'isoquinoléine et leurs procédés de préparation.
BE600294A (fr) Composés pharmaceutiques et leurs procédés de préparation.
BE592672A (fr) Esters de l'oxytétracycline et leurs procédés de préparation.
FR1335205A (fr) Nouvelles alcanamides-hydrazines nu- substituées et leurs procédés de préparation
FR1366718A (fr) Dérivés de pyrazine et procédés pour les préparer
BE612886A (fr) Nouveaux dérivés de la phénothiazine et leurs procédés de préparation
BE612885A (fr) Nouveaux dérivés de la phénothiazine et leurs procédés de préparation
FR1364M (fr) Dérivés de l'acridane.